Powering High-Value Decisions with
Precision Insights
Since 1998, Kalorama, part of Science and Medicine Group, has been a trusted leader in life science market intelligence for top IVD manufacturers, investors, and healthcare stakeholders. While others spread thin across multiple verticals, we go deep – specializing in sectors like IVD, medical devices, biotechnology, and pharmaceuticals. Our goal is simple: turn data into clear actionable insights so business can make smarter decisions, identify growth opportunities, and stay ahead of change.
Industries We Serve
Healthcare • Biotechnology • Laboratory Diagnostics • Medical Devices • Pharmaceuticals
Our Solutions
Explore our comprehensive suite of solutions, designed to drive your success. Why? Because when you succeed, science and medicine move forward.
Latest Resource
The Quiet Engine of Modern Medicine: Where Clinical Laboratory Services Are Headed
October 19, 2026
Daniel Granderson
Clinical laboratories rarely make headlines, yet they’re involved in most medical decisions. Diagnosing disease, selecting treatments, monitoring patients, and detecting recurrence all depend on laboratory testing. The work happens largely behind the scenes, which is one reason the industry is often overlooked when discussing the future of healthcare. That may be changing. According to Kalorama…
Latest Market Reports
Our syndicated reports are vital tools for companies aiming to develop and implement effective market strategies. View our latest reports below.
Worldwide Market for Hematology, 2026–2031
October 13, 2026
Kalorama’s Worldwide Market for Hematology, 2026-2031 sizes and forecasts global laboratory-based and point-of-care hematology testing, with vendor shares, regional breakouts, and technology trends.
Price range: $5,600.00 through $8,000.00
The World Market for Clinical Sequencing and Sequencing-Based IVD Products, 2026
September 22, 2026
Kalorama’s World Market for Clinical Sequencing and Sequencing-Based IVD Products, 2026 analyzes clinical sequencing instruments, consumables, software, and diagnostic products, with forecasts through 2030.
Price range: $5,600.00 through $8,000.00
Molecular Diagnostics Quarterly Datastream, 2026 (Q4 2025, Q1 2026, Q2 2026, & Q3 2026)
September 21, 2026
The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports.
Price range: $8,050.00 through $11,500.00
Our Customers
